Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Biomedical Sciences Graduate Program, University of California, San Diego, La Jolla, CA 92093, USA; Department of Biomedical Informatics, University of California, San Diego, La Jolla, CA 92093, USA.
Cell Rep. 2018 Jul 24;24(4):883-894. doi: 10.1016/j.celrep.2018.06.091.
To understand the mutational burden of human induced pluripotent stem cells (iPSCs), we sequenced genomes of 18 fibroblast-derived iPSC lines and identified different classes of somatic mutations based on structure, origin, and frequency. Copy-number alterations affected 295 kb in each sample and strongly impacted gene expression. UV-damage mutations were present in ∼45% of the iPSCs and accounted for most of the observed heterogeneity in mutation rates across lines. Subclonal mutations (not present in all iPSCs within a line) composed 10% of point mutations and, compared with clonal variants, showed an enrichment in active promoters and increased association with altered gene expression. Our study shows that, by combining WGS, transcriptome, and epigenome data, we can understand the mutational burden of each iPSC line on an individual basis and suggests that this information could be used to prioritize iPSC lines for models of specific human diseases and/or transplantation therapy.
为了了解人类诱导多能干细胞(iPSC)的突变负担,我们对 18 个源自成纤维细胞的 iPSC 系的基因组进行了测序,并根据结构、起源和频率确定了不同类型的体细胞突变。拷贝数改变影响了每个样本中的 295kb,强烈影响了基因表达。UV 损伤突变存在于约 45%的 iPSC 中,并且解释了跨系观察到的突变率异质性的大部分原因。亚克隆突变(在一条线内的所有 iPSC 中都不存在)占点突变的 10%,与克隆变体相比,它在活性启动子中富集,并与改变的基因表达增加相关。我们的研究表明,通过结合 WGS、转录组和表观基因组数据,我们可以在个体基础上了解每个 iPSC 系的突变负担,并表明该信息可用于为特定人类疾病和/或移植治疗模型优先选择 iPSC 系。